SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-239753
Filing Date
2022-09-07
Accepted
2022-09-07 11:35:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d355636ddefa14a.htm DEFA14A 11160
  Complete submission text file 0001193125-22-239753.txt   12395
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33057 | Film No.: 221230385
SIC: 2834 Pharmaceutical Preparations